Table 1.
General guidelines for print accessibility | Guidelines for legibility of prescription labelling | |||||||
---|---|---|---|---|---|---|---|---|
CNIB (Canada) | RNIB (UK) | ACB (US) | USP (US) | ASCP (US) | MPAG (Sweden) | NPSA (UK) | AFB (US) | |
Font style and point size | Sans-serif font Minimum 12, 14, 18 points |
Sans-serif font Minimum 12, 14 points |
Sans-serif font Minimum 18 points |
Sans-serif font Minimum 12 points |
Sans-serif font Minimum 18 points for vision loss |
Times New Roman font 9 points or more |
Font such as Arial Minimum 12 points |
Sans-serif font Largest font possible, 18 points for vision loss |
Case | Not all upper case | Not all upper case | Not all upper case | Sentence case | Sentence case | Avoid upper case | Avoid overuse of upper case | Not all upper case |
Bolding | For emphasis | Use sparingly | Use bold | Use bold for emphasizing important information | Use bold for most important information | Use bold for most important information | Use bold for most important information | |
Italics | Not recommended | Italics harder to read | Do not use | Do not use | Do not use | |||
Paper type | High contrast Nonglossy |
High contrast Nonglossy |
High contrast Nonglossy |
CNIB, Canadian National Institute for the Blind13; RNIB, Royal National Institute of Blind People14; ACB, American Council of the Blind15; USP, United States Pharmacopeia16; ASCP, American Society of Consultant Pharmacists17; MPAG, Medical Products Agency Guidelines (Sweden)18; NPSA, National Patient Safety Agency (UK)19; AFB, American Foundation for the Blind20